Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-01-01 @ 5:06 PM
Study NCT ID:
NCT05996835
Status:
RECRUITING
Last Update Posted:
2025-12-23
First Post:
2023-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04-21
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-10
First Submit QC Date:
None
Study First Post Date:
2023-08-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-22
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED